Feasibility of Mesenchymal Stem Cell Therapy for COVID-19: A Mini Review

Patients infected with SARS-CoV-2 carry the coronavirus disease 2019 (COVID-19) which involves multiple systems and organs with acute respiratory distress syndrome (ARDS) as the most common complication, largely due to cytokine storms or dysregulated immunity. As such, there are many severe patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jingwen, Wang, Xinyi, Li, Na, Jiang, Ying, Huang, Heqing, Wang, Tao, Lin, Zhicheng, Xiong, Nian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388062/
https://www.ncbi.nlm.nih.gov/pubmed/32867652
http://dx.doi.org/10.2174/1566523220999200820172829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388062/
https://www.ncbi.nlm.nih.gov/pubmed/32867652
http://dx.doi.org/10.2174/1566523220999200820172829

Ejemplares similares